European Journal of Cancer
Volume 41, Issue 13 , Pages 1911-1922 , September 2005

How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men

Received 31 March 2005 ,Revised 13 June 2005 ,Accepted 15 June 2005.

References 

  1. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol. 2005;23(2):378–391
  2. ObermuellerJevic UC, Espiritu I, Corbacho AM, et al. Lung tumor development in mice exposed to tobacco smoke and fed beta-carotene diets. Toxicol Sci. 2002;69(1):23–29
  3. Forman MR, Hursting SD, Umar A, et al. Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Annu Rev Nutr. 2004;24:223–254
  4. Pound P, Ebrahim S, Sandercock P, et al. Where is the evidence that animal research benefits humans?. Br Med J. 2004;328(7438):514–517
  5. Gescher AJ, Steward WP. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev. 2003;12(10):953–957
  6. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–170
  7. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310
  8. Xing Y, Clements WK, Kimelman D, et al. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex. Gen Dev. 2003;17(22):2753–2764
  9. Clevers H. Wnt breakers in colon cancer. Cancer Cell. 2004;5(1):5–6
  10. Fodde R, Kuipers J, Rosenberg C, et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol. 2001;3(4):433–438
  11. Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer. 2003;2(41):1–15
  12. Chung D, Rustgi A. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Int Med. 2003;138(7):560–570
  13. Trinh BN, Long TI, Nickel A, et al. DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol Cell Biol. 2002;22(9):2906–2917
  14. Femia AP, Bendinelli B, Giannini A, et al. Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of1,2-dimethylhydrazine-treated rats. Int J Cancer. 2005;116(1):9–15
  15. Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 2004;95(6):475–480
  16. Tsukamoto T, Tanaka H, Fukami H, Inoue M, Takahashi M, Wakabayashi K, et al. More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (phIP)-treated rats. Jpn J Cancer Res. 2000;91(8):792–796
  17. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247:322–324
  18. Corpet DE, Pierre F. Point: from animal models to prevention of colon cancer. systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomar Prev. 2003;12(5):391–400
  19. Ahn B, Ohshima H. Suppression of intestinal polyposis in Apc (Min/+) mice by inhibiting nitric oxide production. Cancer Res. 2001;61(23):8357–8360
  20. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in apc (delta 716) knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996;87(5):803–809
  21. Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasi by DNA hypomethylation. Cell. 1995;81(2):197–205
  22. DeWind N, Dekker M, VanRossum A, et al. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res. 1998;58(2):248–255
  23. Wei K, Kucherlapati R, Edelmann W. Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med. 2002;8(7):346–353
  24. Green JE, Hudson T. The promise of genetically engineered mice for cancer prevention studies. Nat Rev Cancer. 2005;5(3):184–198
  25. Colnot S, Niwa-Kawakita M, Hamard G, et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest. 2004;84(12):1619–1630
  26. Orner GA, Dashwood WM, Blum CA, et al. Response of Apc (min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (phIP. Mutat Res—Fundam Mol Mech Mutagen. 2002;506(Sp. Iss.):121–127
  27. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Eng J Med. 1999;340(2):101–107
  28. BonithonKopp C, Kronborg O, Giacosa A, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. Lancet. 2000;356(9238):1300–1306
  29. Hofstad B, Almendingen K, Vatn M, et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion. 1998;59(2):148–156
  30. Baron JA, Cole BF, Sandler RS, et al. A randomised trial of aspirin to prevent colorectal adenomas. N Eng J Med. 2003;348(10):891–899
  31. Sandler RS, Halabi S, Baron JA, et al. A randomised trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Eng J Med. 2003;348(10):883–890
  32. Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 2003;125(2):328–336
  33. Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomised controlled trials. Am J Gastroenterol. 2005;100(2):390–394
  34. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Eng J Med. 2000;342(16):1156–1162
  35. MacLennan R, Macrae F, Bain C, et al. Randomised trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Nat Cancer Inst. 1995;87(23):1760–1766
  36. McKeown-Eyssen G, Holloway C, Jazmaji V, et al. A randomised trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res. 1988;48:4701–4705
  37. McKeown-Eyssen GE, Bright-See E, Bruce WR, et al. Toronto-Polyp-Prevention-Group. A randomised trial of a low fat high fibre diet in the recurrence of colorectal polyps. J Clin Epidemiol. 1994;47(5):525–536
  38. Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Eng J Med. 2000;342(16):1149–1155
  39. Greenberg ER, Baron JA, Tosteson TD, et al. Clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Eng J Med. 1994;331(3):141–147
  40. Cucherat M, Boissel JP, Leizorovicz A. EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Progr Biomed. 1997;53:187–190
  41. Craven PA, Derubertis FR. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis. 1992;13(4):541–546
  42. Reddy BS, Rao CV, Rivenson A, et al. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in f344 rats. Carcinogenesis. 1993;14(8):1493–1497
  43. Davis AE, Patterson F. Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. Austral N Zeal Med. 1994;24(3):301–303
  44. Pence BC, Dunn DM, Zhao C, et al. Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis. 1995;16(4):757–765
  45. Li H, Schut HAJ, Conran P, et al. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin e-2 levels in rat colon. Carcinogenesis. 1999;20(3):425–430
  46. Barnes CJ, Lee M. Determination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats. Br J Cancer. 1999;79(11–12):1646–1650
  47. Molck AM, Poulsen M, Meyer O. The combination of 1alpha,25 (OH2)-vitamin D3, calcium and acetylsalicylic acid affects azoxymethane-induced aberrant crypt foci and colorectal tumours in rats. Cancer Lett. 2002;186(1):19–28
  48. Miliaras S, Miliaras D, Vrettou E, et al. The effect of aspirin and high fibre diet on colorectal carcinoma: a comparative experimental study. Tech Coloproctol. 2004;8(Suppl 1):s59–s61
  49. Mahmoud NN, Dannenberg AJ, Mestre J, et al. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery. 1998;124(2):225–231
  50. Barnes CJ, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli min mouse model with aspirin. Gastroenterology. 1998;114(5):873–877
  51. Williamson SLH, Kartheuser A, Coaker J, et al. Intestinal tumorigenesis in the apc1638n mouse treated with aspirin and resistant starch for up to 5 months. Carcinogenesis. 1999;20(5):805–810
  52. Chiu CH, McEntee MF, Whelan J. Discordant effect of aspirin and indomethacin on intestinal tumor burden in Apc (Min/+)mice. Prostagland Leukot Essent Fatty Acids. 2000;62(5):269–275
  53. Sansom OJ, Stark LA, Dunlop MG, Clarke AR. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc (min/+) and Apc (min/+), Msh2 (-/-) mice. Cancer Res. 2001;61(19):7060–7064
  54. Reuter BK, Zhang XJ, Miller MJ. Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis. BMC Cancer. 2002;2(1):19
  55. Perkins S, Clarke AR, Steward W, et al. Age-related difference in susceptibility of Apc (Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin. Br J Cancer. 2003;88(9):1480–1483
  56. Colacchio TA, Memoli VA. Chemoprevention of colorectal neoplasms. Ascorbic acid and beta-carotene. Arch Surg. 1986;121(12):1421–1424
  57. Temple NJ, Basu TK. Protective effect of beta-carotene against colon tumors in mice. J Natl Cancer Inst. 1987;78(6):1211–1214
  58. Imaida K, Hirose M, Yamaguchi S, et al. Effects of naturally occuring antioxydants on combined DMH and MNU intitated carcinogenesis in F344 male rats. Cancer Lett. 1990;55:53–59
  59. Yamamoto I, Maruyama H, Moriguchi M. Effect of beta-carotene, sodium ascorbate and cellulose on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in rats. Cancer Lett. 1994;86(1):5–9
  60. Bull A, Bird RP, Bruce WR, et al. Effect of calcium on azoxymethane induced intestinal tumors in rats. Gastroenterology. 1987;92(5, 2):#1332
  61. Nelson RL, Tanure JC, Andrianopoulos G. The effect of dietary milk and calcium on experimental colorectal carcinogenesis. Dis Colon Rect. 1987;30(12):947–949
  62. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis. 1988;9(1):187–190
  63. McSherry CK, Cohen BI, Scholes J. Effect of calcium and bile acid feeding on colon tumors in the rat. Cancer Res. 1989;49:6039–6043
  64. Wargovich MJ, Allnutt D, Palmer C, et al. Inhibition of the promotional phase of azoxymethane induced colon carcinogenesis in the F344 rat by calcium lactate : effect of simulationg 2 human nutrient density levels. Cancer Lett. 1990;53:17–25
  65. Sitrin MD, Halline AG, Abrahams C, et al. Dietary Calcium and Vitamin-D Modulate 1,2-Dimethylhydrazine-Induced Colonic Carcinogenesis in the Rat. Cancer Res. 1991;51(20):5608–5613
  66. Karkare MR, Clark TD, Glauert HP. Effect of dietary calcium on colon carcinogenesis induced by a single injection of 1,2-dimethylhydrazine in rats. J Nutr. 1991;121(4):568–577
  67. Barsoum GH, Thompson H, Neoptolemos JP, et al. Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferation. Gut. 1992;33(11):1515–1520
  68. Beaty MM, Lee EY, Glauert HP. Influence of dietary calcium and vitamin-d on colon epithelial cell proliferation and 1,2-dimethylhydrazine-induced colon carcinogenesis in rats fed high fat diets. J Nutr. 1993;123(1):144–152
  69. Pence BC, Dunn DM, Zhao C, et al. Protective effects of calcium from nonfat dried milk against colon carcinogenesis in rats. Nutr Cancer. 1996;25(1):35–45
  70. Belbraouet S, Felden F, Pelletier X, et al. Dietary calcium salts as protective agents and laminin P1 as a biochemical marker in chemically induced colon carcinogenesis in rats. Cancer Detect Prev. 1996;20(4):294–299
  71. Quilliot D, Belbraouet S, Pelletier X, et al. Influence of a high-calcium carbonate diet on the incidence of experimental colon cancer in rats. Nutr Cancer. 1999;34(2):213–219
  72. VinasSalas J, BiendichoPalau P, PinolFelis C, et al. Calcium inhibits colon carcinogenesis in an experimental model in the rat. Eur J Cancer. 1998;34(12):1941–1945
  73. Adell-Carceller R, Segarra-Soria M, Gibert-Jerez J, et al. Inhibitory effect of calcium on carcinogenesis at the site of colonic anastomosis: an experimental study. Dis Colon Rect. 1997;40(11):1376–1381
  74. Behling AR, Kaup SM, Choquette LL, et al. Lipid absorption and intestinal tumour incidence in rats fed on varying levels of calcium and butterfat. Br J Nutr. 1990;64(2):505–513
  75. Ranhotra GS, Gelroth JA, Glaser BK, et al. Cellulose and calcium lower the incidence of chemically-induced colon tumors in rats. Plant Foods Hum Nutr. 1999;54(4):295–303
  76. Huerta S, Irwin RW, Heber D, et al. Intestinal polyp formation in the Apc (Min) mouse – effects of levels of dietary calcium and altered vitamin d homeostasis. Digest Dis Sci. 2003;48(5):870–876
  77. Yang K, Edelmann W, Fan KH, et al. Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Res. 1998;58(24):5713–5717
  78. Yang WC, Bancroft L, Nicholas C, et al. Targeted inactivation of p27 (kip1) is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a western-style high-risk diet. Cancer Res. 2003;63(16):4990–4996
  79. Yang WC, Mathew J, Velcich A, et al. Targeted inactivation of the p21 (WAF1/cip1) gene enhances apc-initiated tumor formation and the tumor-promoting activity of a western-style high-risk diet by altering cell maturation in the intestinal mucosa. Cancer Res. 2001;61(2):565–569
  80. Barbolt TA, Abraham R. Dose-response, sex difference, and the effect of bran in dimethylhydrazine-induced intestinal tumorigenesis in rats. Toxicol Appl Pharmacol. 1980;55(3):417–422
  81. Barbolt TA, Abraham R. The effect of bran on dimethylhydrazine-induced colon carcinogenesis in the rat. Proc Soc Exp Biol Med. 1978;157(4):656–659
  82. Watanabe K, Reddy BS, Weisburger JH, et al. Effect of dietary alfalfa, pectin, and wheat bran on azoxymethane- or methylnitrosourea-induced colon carcinogenesis in F344 rats. J Natl Cancer Inst. 1979;63(1):141–145
  83. Reddy BS, Mori H, Nicolais M. Effect of dietary wheat bran and dehydrated citrus fiber on azoxymethane-induced intestinal carcinogenesis in Fischer 344 rats. J Natl Cancer Inst. 1981;66(3):553–557
  84. Jacobs LR. Enhancement of rat colon carcinogenesis by wheat bran consumption during the stage of 1,2-dimethylhydrazine administration. Cancer Res. 1983;43(9):4057–4061
  85. Pence BC, Budding HF, Yang SP. Multiple dietary factors in the enhancement of dimethylhydrazine carcinogenesis: main effect of indole-3-carbinol. J Nat Cancer Inst. 1986;77:269–276
  86. Sinkeldam EJ, Kuper CF, Bosland MC, et al. Interactive effects of dietary wheat bran and lard on N-methyl-N’-nitro-N-nitrosoguanidine induced colon carcinogenesis in rats. Cancer Res. 1990;50:1092–1096
  87. Kritchevsky D, Klurfeld DM. Interaction of fiber and energy restriction in experimental colon carcinogenesis. Cancer Lett. 1997;114(1–2):51–52
  88. Takahashi T, Satou M, Watanabe N, et al. Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice. Cancer Lett. 1999;141(1–2):139–146
  89. McIntosh GH, Royle PJ, Pointing G. Wheat aleurone flour increases cecal beta-glucuronidase activity and butyrate concentration and reduces colon adenoma burden in azoxymethane-treated rats. J Nutr. 2001;131(1):127–131
  90. Wijnands MVW, van Erk MJ, Doornbos RP, et al. Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours. Food Chem Toxicol. 2004;42(10):1629–1639
  91. Reddy BS, Mori H. Effect of dietary wheat bran and dehydrated citrus fiber on 3,2’-dimethyl-4-aminobiphenyl-induced intestinal carcinogenesis in F344 rats. Carcinogenesis. 1981;2(1):21–25
  92. Mutanen M, Pajari AM, Oikarinen SI. Beef induces and rye bran prevents the formation of intestinal polyps in apc (min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis. 2000;21(6):1167–1173
  93. Pierre F, Perrin P, Champ M, et al. Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in min mice. Cancer Res. 1997;57(2):225–228
  94. Hioki K, Shivapurkar N, Oshima H, et al. Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc (delta 716) knockout mice. Carcinogenesis. 1997;18(10):1863–1865
  95. Yu Z, Xu M, Santanarios G, et al. A comparison of whole wheat, refined wheat and wheat bran as inhibitors of heterocyclic amines in the salmonella mutagenicity assay and in the rat colonic aberrant crypt focus assay. Food Chem Toxicol. 2001;39(7):655–665
  96. Drankhan K, Carter J, Madl R, et al. Antitumor activity of wheats with high orthophenolic content. Nutr Cancer. 2003;47(2):188–194
  97. Toth B. Effect of Metamucil on tumour formation by 1,2-dimethylhydrazine dihydrochloride in mice. Food Chem Toxicol. 1984;22(7):573–578
  98. Newmark HL, Yang K, Lipkin M, et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis. 2001;22(11):1871–1875
  99. Bruce WR. Counterpoint: from animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies. Cancer Epidemiol Biomarkers Prev. 2003;12(5):401–404
  100. Corpet DE, Parnaud G. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 1999;20(5):915–918
  101. Dorval ED, Viguier J, Bertrand P, et al. Prevention of colorectal adenomas by polyethylene glycol (PEG): a population-based study of 1165 colonoscopies in France. Proc AACR. 2003;44(2nd ed.):174;#979
  102. Pierre F, Freeman A, Tache S, et al. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr. 2004;134(10):2711–2716
  103. Pierre F, Tache S, Petit CR, et al. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24(10):1683–1690
  104. Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?. Semin Oncol. 2005;32(1):24–34
  105. Harris PJ, Ferguson LR. Dietary fibre – its composition and role in protection against colorectal cancer. Mutat Res. 1993;290(1):97–110
  106. Bird RP. Observation and quantification of aberrant crypts in murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147–151
  107. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Eng J Med. 1998;339(18):1277–1284
  108. Reichling T, Goss KH, Carson DJ, et al. Transcriptional profiles of intestinal tumors in Apc (Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res. 2005;65(1):166–176

PII: S0959-8049(05)00476-4

doi: 10.1016/j.ejca.2005.06.006

European Journal of Cancer
Volume 41, Issue 13 , Pages 1911-1922 , September 2005

Article Tools

* Image Usage & Resolution